Literature DB >> 27493008

Can we use structural lesions seen on MRI of the sacroiliac joints reliably for the classification of patients according to the ASAS axial spondyloarthritis criteria? Data from the DESIR cohort.

Pauline A C Bakker1, Rosaline van den Berg1, Gregory Lenczner2, Fabrice Thévenin3, Monique Reijnierse4, Pascal Claudepierre5, Daniel Wendling6, Maxime Dougados7, Désirée van der Heijde1.   

Abstract

OBJECTIVES: Investigating the utility of adding structural lesions seen on MRI of the sacroiliac joints to the imaging criterion of the Assessment of SpondyloArthritis (ASAS) axial SpondyloArthritis (axSpA) criteria and the utility of replacement of radiographic sacroiliitis by structural lesions on MRI.
METHODS: Two well-calibrated readers scored MRI STIR (inflammation, MRI-SI), MRI T1-w images (structural lesions, MRI-SI-s) and radiographs of the sacroiliac joints (X-SI) of patients in the DEvenir des Spondyloarthrites Indifférenciées Récentes cohort (inflammatory back pain: ≥3 months, <3 years, age <50). A third reader adjudicated MRI-SI and X-SI discrepancies. Previously proposed cut-offs for a positive MRI-SI-s were used (based on <5% prevalence among no-SpA patients): erosions (E) ≥3, fatty lesions (FL) ≥3, E/FL ≥5. Patients were classified according to the ASAS axSpA criteria using the various definitions of MRI-SI-s.
RESULTS: Of the 582 patients included in this analysis, 418 fulfilled the ASAS axSpA criteria, of which 127 patients were modified New York (mNY) positive and 134 and 75 were MRI-SI-s positive (E/FL≥5) for readers 1 and 2, respectively. Agreement between mNY and MRI-SI-s (E/FL≥5) was moderate (reader 1: κ: 0.39; reader 2: κ: 0.44). Using the E/FL≥5 cut-off instead of mNY classification did not change in 478 (82.1%) and 469 (80.6%) patients for readers 1 and 2, respectively. Twelve (reader 1) or ten (reader 2) patients would not be classified as axSpA if only MRI-SI-s was performed (in the scenario of replacement of mNY), while three (reader 1) or six (reader 2) patients would be additionally classified as axSpA in both scenarios (replacement of mNY and addition of MRI-SI-s). Similar results were seen for the other cut-offs (E≥3, FL≥3).
CONCLUSIONS: Structural lesions on MRI can be used reliably either as an addition to or as a substitute for radiographs in the ASAS axSpA classification of patients in our cohort of patients with short symptom duration. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Ankylosing Spondylitis; Low Back Pain; Magnetic Resonance Imaging; Spondyloarthritis

Mesh:

Year:  2016        PMID: 27493008     DOI: 10.1136/annrheumdis-2016-209405

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

Review 1.  Diagnostic imaging: pitfalls in rheumatology.

Authors:  Marcello Zappia; Nicola Maggialetti; Raffaele Natella; Alfonso Reginelli; Federico Bruno; Francesco Di Pietto; Luca Brunese
Journal:  Radiol Med       Date:  2019-03-06       Impact factor: 3.469

2.  Sacroiliac joints: anatomical variations on MR images.

Authors:  Mazen El Rafei; Sammy Badr; Guillaume Lefebvre; Francois Machuron; Benoist Capon; Rene-Marc Flipo; Anne Cotten
Journal:  Eur Radiol       Date:  2018-06-06       Impact factor: 5.315

3.  Clinical characteristics, treatment and outcomes of acute postpartum inflammatory sacroiliitis: a retrospective study.

Authors:  Xiaoxu Lu; Jiajia Hu; Minhui Dai; Jian Wang; Jianqin Yan; Junjie Zhang; Chengliang Zhang
Journal:  Arch Gynecol Obstet       Date:  2022-04-08       Impact factor: 2.344

Review 4.  Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022.

Authors:  Ann-Sophie De Craemer; Zuzanna Łukasik; Philippe Carron
Journal:  Curr Rheumatol Rep       Date:  2022-10-15       Impact factor: 4.686

5.  Unilateral sacroiliitis: differentiating infective and inflammatory etiology by magnetic resonance imaging and tissue studies.

Authors:  Rishi Mugesh Kanna; Aju Bosco; Ajoy Prasad Shetty; S Rajasekaran
Journal:  Eur Spine J       Date:  2018-10-23       Impact factor: 3.134

6.  What is the reliability of non-trained investigators in recognising structural MRI lesions of sacroiliac joints in patients with recent inflammatory back pain? Results of the DESIR cohort.

Authors:  Charlotte Jacquemin; Roxana Rubio Vargas; Rosaline van den Berg; Fabrice Thévenin; Gregory Lenczner; Monique Reijnierse; Salah Ferkal; Philippe Le Corvoisier; Alain Rahmouni; Damien Loeuille; Antoine Feydy; Maxime Dougados; Désirée van der Heijde; Pascal Claudepierre
Journal:  RMD Open       Date:  2016-11-11

7.  Evaluation of the performances of 'typical' imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study.

Authors:  Anna Molto; Laure Gossec; Marie-Martine Lefèvre-Colau; Violaine Foltz; Romain Beaufort; Jean-Denis Laredo; Pascal Richette; Philippe Dieude; Philippe Goupille; Antoine Feydy; Maxime Dougados
Journal:  RMD Open       Date:  2019-05-28

8.  MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis.

Authors:  Chun-Chi Lu; Guo-Shu Huang; Tony Szu-Hsien Lee; En Chao; Hsiang-Cheng Chen; Yong-Si Guo; Shi-Jye Chu; Feng-Cheng Liu; San-Yuan Kao; Tsung-Yun Hou; Chen-Hung Chen; Deh-Ming Chang; Sin-Yi Lyu
Journal:  J Transl Med       Date:  2021-07-09       Impact factor: 5.531

9.  Is it Useful to Repeat Magnetic Resonance Imaging of the Sacroiliac Joints After Three Months or One Year in the Diagnosis of Patients With Chronic Back Pain and Suspected Axial Spondyloarthritis?

Authors:  P A C Bakker; S Ramiro; Z Ez-Zaitouni; M van Lunteren; I J Berg; R Landewé; R Ramonda; M van Oosterhout; M Reijnierse; F A van Gaalen; D van der Heijde
Journal:  Arthritis Rheumatol       Date:  2019-02-06       Impact factor: 10.995

10.  Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.

Authors:  Monika Hebeisen; Raphael Micheroli; Almut Scherer; Xenofon Baraliakos; Manouk de Hooge; Désirée van der Heijde; Robert Landewé; Kristina Bürki; Michael J Nissen; Burkhard Möller; Pascal Zufferey; Pascale Exer; Adrian Ciurea
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.